← All diseases

Blood and immune system diseases

Hereditary spherocytosis

An inherited blood disease in which red blood cells are round like a ball. These cells are destroyed early in the spleen. Anemia, jaundice and an enlarged spleen occur.

Not part of the panel of Türkiye's National Newborn Screening Programme (heel-prick test). Source

This page is translated from the Turkish original.

This disease is followed through the “Blood and immune system diseases” group.

Understanding the disease

This section has not yet been reviewed by a physician. It summarises patient information from sources such as MedlinePlus, Orphanet and the NHS in plain language. The disease can differ from person to person; talk to your doctor about diagnosis and treatment.

What happens in this disease?

Red blood cells are normally flat and flexible. In this disease, some proteins in the cell membrane are faulty. The cells become stiff and take on a ball shape. These cells get trapped in the spleen and break down early. The disease has different forms, from mild to severe.

Which symptoms can occur?

Symptoms vary greatly from person to person. In the mild form, there may be no symptoms at all.

  • Anemia, paleness and tiredness
  • Yellowing of the skin and eyes
  • Enlarged spleen
  • Gallstones (in about half)
  • Anemia in newborns; it often becomes milder after the first year
  • A sudden worsening of anemia after a viral infection (sometimes)
  • Short stature and bone problems in the severe form (rare)

How is it diagnosed?

During the examination, the doctor checks the size of the spleen. Ball-shaped cells are seen in the blood count and blood smear. Tests showing the breakdown of blood and special cell membrane tests are done. A genetic test is not always needed, but it can clarify the diagnosis.

Treatment and care

In moderate and severe forms, supplements of folate, a B vitamin, are recommended. Blood transfusions may be needed for severe anemia. In severe cases, removing the spleen greatly improves the anemia. In children, this surgery is usually delayed for a few years. Vaccines are given before the surgery. In mild cases, the spleen may not need to be removed. If gallstones cause problems, the gallbladder may be removed. The doctor who follows the disease decides which treatment is suitable.

For the family: inheritance and genetic counselling

About three quarters of cases are passed on through dominant inheritance. An affected parent has a 1 in 2 chance of passing it to each child. Sometimes the gene change appears for the first time in the family. The remaining cases are passed on through recessive inheritance. In this case, for a couple who are both carriers, the chance of having an affected child is 1 in 4 in each pregnancy. If the disease is in the family, checking the children is recommended. Genetic counselling guides the family.

Source: MedlinePlus Genetics: Hereditary spherocytosis · MedlinePlus: Hereditary spherocytic anemia · NORD: Hereditary Spherocytosis

Key facts

How common is it?
Prevalence: 1-5 per 10 000 (Europe)
When does it usually start?
Any age
Gene(s) involved
SLC4A1, SPTA1, SPTB, ANK1, EPB42

These facts are taken from Orphanet and MedlinePlus records (last checked: October 7, 2026). Frequency values are approximate ranges.

You are not alone: patient associations in Türkiye

Non-profit patient and family organizations in Türkiye working on this disease or disease group. Links are for information; Doktorclub is not affiliated with these organizations and does not endorse them.

We could not find a patient association specific to this disease.

For all rare diseases: Nadir Hastalıklar Federasyonu

Support and help

Doktorclub does not diagnose, recommend treatments or refer you to hospitals or doctors. These pages are meant to help you talk with your doctor.

News about Spherocytosis

Clinical trials (ClinicalTrials.gov)

A clinical trial is a regulated study that tests whether a new treatment is safe and whether it works, in patients who volunteer. Most trials look for a certain age, genetic change and health condition. Taking part is voluntary.

This list is not a treatment recommendation. Treatments tested in phase 1–3 trials are investigational (experimental): their efficacy and safety have not yet been proven and they are not approved treatments. Taking part depends on each trial’s criteria and a physician’s assessment; the first step is to talk to the doctor who manages your care.

ClinicalTrials.gov currently lists no active interventional studies for this disease. Last checked: October 7, 2026.

See all studies on ClinicalTrials.gov · Joining clinical trials

Blood and immune system diseases: other news

Medical codes (for talking with your doctor and finding sources)

These codes identify the disease in international classifications and databases. They can help when you talk with your doctor or look for reliable sources.

Orphanet code: ORPHA:822

No separate ICD-11 code; WHO classifies this disease under: 3A10.Y

Codes checked against WHO ICD-11 and Orphanet on October 7, 2026.

This page provides general information and does not replace diagnosis or treatment. Talk to your doctor about symptoms, diagnosis and treatment.

The information on these pages is for general information only and does not replace medical advice. Talk to your doctor about diagnosis and treatment decisions. In an emergency in Türkiye, call 112.

Every update is based on an open source and labeled with its level of evidence. No advertising and no drug brand names. Our scientific principles

This page was translated from Turkish by the Doktorclub editorial team.